Goldman Sachs raised the firm’s price target on Rocket Companies (RKT) to $22 from $16 and keeps a Neutral rating on the shares. Published first ...
H.C. Wainwright raised the firm’s price target on Unicycive Therapeutics (UNCY) to $22 from $9 and keeps a Buy rating on the shares. The believes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback